MktsMarkets

Praxis Precision Medicines, Inc.
NASDAQ: PRAXKey statistics
PRAX News
Stories mentioning PRAX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 302.00 | 357.00 | ||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 77,987 | 77,506 | 65,797 | 63,006 | 60,806 | 41,881 | 27,260 | |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 105,860 | 97,044 | 78,359 | 76,067 | 74,728 | 57,137 | 37,845 | |
| Operating Income (Loss) | (105,860) | (97,044) | (78,359) | (76,067) | (74,728) | (56,835) | (37,488) | |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 13,299 | 8,133 | 4,425 | 4,940 | 5,432 | 4,925 | 4,811 | |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (92,561) | (88,911) | (73,934) | (71,127) | (69,296) | (58,679) | (51,910) | (32,677) |
| Earnings Per Share (Basic) | (3.20) | (3.95) | (3.36) | (3.31) | (3.29) | (3.28) | (2.75) | (1.74) |
| Earnings Per Share (Diluted) | (3.20) | (3.95) | (3.36) | (3.31) | (3.29) | (3.28) | (2.75) | (1.74) |
| Weighted Average Shares Outstanding (Basic) | 28,884 | 22,505 | 21,977 | 21,475 | 21,056 | 17,907 | 18,885 | 18,824 |
| Weighted Average Shares Outstanding (Diluted) | 28,884 | 22,505 | 21,977 | 21,475 | 21,056 | 17,907 | 18,885 | 18,824 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PRAX
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is a stock listed on the Nasdaq Stock Market under the ticker symbol PRAX. It last traded at $264.49 (Oct 20, 2026, 4:00 PM ET), up 1.7% on the day. That gives Praxis Precision Medicines a market capitalisation of $7.4B.
Over the past 52 weeks PRAX has traded between $154.45 and $392.70.
For the quarter ended Mar 31, 2026 it reported a net loss of $92.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$92.6M |
| Dec 31, 2025 | $0 | -$88.9M |
| Sep 30, 2025 | $0 | -$73.9M |
| Jun 30, 2025 | $0 | -$71.1M |
From Praxis Precision Medicines’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…